The regulation of muscle mass by endogenous glucocorticoids

被引:181
|
作者
Braun, Theodore P. [1 ,2 ]
Marks, Daniel L. [1 ]
机构
[1] Univ Washington, Med Ctr, Dept Internal Med, Seattle, WA 98195 USA
[2] Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Portland, OR 97239 USA
来源
FRONTIERS IN PHYSIOLOGY | 2015年 / 6卷
基金
加拿大健康研究院;
关键词
glucococorticoids; muscle; skeletal; HPA-axis; cachexia; catabolism; wasting; protein synthesis; 1 NULL MICE; SKELETAL-MUSCLE; GENE-EXPRESSION; OXIDATIVE STRESS; DNA-BINDING; PROTEIN-DEGRADATION; PROTEOLYTIC SYSTEM; UBIQUITIN LIGASES; CANCER CACHEXIA; ATROPHY INVOLVE;
D O I
10.3389/fphys.2015.00012
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Glucocorticoids are highly conserved fundamental regulators of energy homeostasis. In response to stress in the form of perceived danger or acute inflammation, glucocorticoids are released from the adrenal gland, rapidly mobilizing energy from carbohydrate, fat and protein stores. In the case of inflammation, mobilized protein is critical for the rapid synthesis of acute phase reactants and an efficient immune response to infection. While adaptive in response to infection, chronic mobilization can lead to a profound depletion of energy stores. Skeletal muscle represents the major body store of protein, and can become substantially atrophied under conditions of chronic inflammation. Glucocorticoids elicit the atrophy of muscle by increasing the rate of protein degradation by the ubiguitin-proteasome system and autophagy lysosome system. Protein synthesis is also suppressed at the level of translational initiation, preventing the production of new myofibrillar protein. Glucocorticoids also antagonize the action of anabolic regulators such as insulin further exacerbating the loss of protein and muscle mass. The loss of muscle mass in the context of chronic disease is a key feature of cachexia and contributes substantially to morbidity and mortality. A growing body of evidence demonstrates that glucocorticoid signaling is a common mediator of wasting, irrespective of the underlying initiator or disease state. This review will highlight fundamental mechanisms of glucocorticoid signaling and detail the mechanisms of glucocorticoid-induced muscle atrophy. Additionally, the evidence for glucocorticoids as a driver of muscle wasting in numerous disease states will be discussed. Given the burden of wasting diseases and the nodal nature of glucocorticoid signaling, effective anti-glucocorticoid therapy would be a valuable clinical tool. Therefore, the progress and potential pitfalls in the development of glucocorticoid antagonists for muscle wasting will be discussed.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Emerging roles of osteocytes in the regulation of bone and skeletal muscle mass
    Moin, Md Rameez
    Das, Shubhrajyoti
    Sanyal, Sabyasachi
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2025, 74 (01)
  • [42] The intriguing regulators of muscle mass in sarcopenia and muscular dystrophy
    Sakuma, Kunihiro
    Aoi, Wataru
    Yamaguchi, Akihiko
    FRONTIERS IN AGING NEUROSCIENCE, 2014, 6
  • [43] Stress Resilience and the Dynamic Regulation of Glucocorticoids
    Vitousek, Maren N.
    Taff, Conor C.
    Ryan, Thomas A.
    Zimmer, Cedric
    INTEGRATIVE AND COMPARATIVE BIOLOGY, 2019, 59 (02) : 251 - 263
  • [44] Regulation of muscle mass by growth hormone and IGF-I
    Velloso, C. P.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 154 (03) : 557 - 568
  • [45] Skeletal muscle mass assessment to detect low muscle mass: Regional or total?
    Bahat, Gulistan
    Catikkas, Nezahat Muge
    Karan, Mehmet Akif
    CLINICAL NUTRITION, 2021, 40 (07) : 4642 - 4643
  • [46] Loss of muscle strength during sepsis is in part regulated by glucocorticoids and is associated with reduced muscle fiber stiffness
    Alamdari, Nima
    Toraldo, Gianluca
    Aversa, Zaira
    Smith, Ira
    Castillero, Estibaliz
    Renaud, Guillaume
    Qaisar, Rizwan
    Larsson, Lars
    Jasuja, Ravi
    Hasselgren, Per-Olof
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2012, 303 (10) : R1090 - R1099
  • [47] Down-Regulation of Akt/Mammalian Target of Rapamycin Signaling Pathway in Response to Myostatin Overexpression in Skeletal Muscle
    Amirouche, Adel
    Durieux, Anne-Cecile
    Banzet, Sebastien
    Koulmann, Nathalie
    Bonnefoy, Regis
    Mouret, Catherine
    Bigard, Xavier
    Peinnequin, Andre
    Freyssenet, Damien
    ENDOCRINOLOGY, 2009, 150 (01) : 286 - 294
  • [48] Glucocorticoids Alter CRTC-CREB Signaling in Muscle Cells: Impact on PGC-1α Expression and Atrophy Markers
    Rahnert, Jill A.
    Zheng, Bin
    Hudson, Matthew B.
    Woodworth-Hobbs, Myra E.
    Price, S. Russ
    PLOS ONE, 2016, 11 (07):
  • [49] Involvement of MicroRNAs in the Regulation of Muscle Wasting during Catabolic Conditions
    Soares, Ricardo Jose
    Cagnin, Stefano
    Chemello, Francesco
    Silvestrin, Matteo
    Musaro, Antonio
    De Pitta, Cristiano
    Lanfranchi, Gerolamo
    Sandri, Marco
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (32) : 21909 - 21925
  • [50] Regulation of Muscle Atrophy: Wasting Away from the Outside In: An Introduction
    Urso, Maria L.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2009, 41 (10) : 1856 - 1859